The Utility of Point of Care Test for Soluble ST2 in Predicting Adverse Cardiac Events during Acute Care of ST-Segment Elevation Myocardial Infarction

Figure 2

The incidence of adverse cardiac events between inframedian and supramedian sST2 groups. The adverse cardiac events were significantly higher (38.3%) in the supramedian group as compared to the inframedian group (12.5%); value for the difference was 0.04 (chi-squared test).